We still need to hit hard in acute myeloid leukemia, but only in the right patients
Not available.
Saved in:
| Main Author: | Arnold Ganser |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2025-01-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/11899 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of Somatic Mutations Are Associated with SNP in the Progression of Individual Acute Myeloid Leukemia Patient: The Two-Hit Theory Explains Inherited Predisposition to Pathogenesis
by: Soyoung Park, et al.
Published: (2013-03-01) -
CAR-T Cell Therapy for Acute Myeloid Leukemia: Where Do We Stand Now?
by: Pilar Lloret-Madrid, et al.
Published: (2025-05-01) -
What have we learned about TP53-mutated acute myeloid leukemia?
by: Moazzam Shahzad, et al.
Published: (2024-11-01) -
What Is Acute Myeloid Leukemia?
by: Daniel Mazza Matos, et al.
Published: (2025-06-01) -
Acute Myeloid Leukemia Presenting as Acute Appendicitis
by: Sherri Rauenzahn, et al.
Published: (2013-01-01)